Cyclacel Pharmaceuticals Files 8-K on Financials
Ticker: BGMSP · Form: 8-K · Filed: May 15, 2025 · CIK: 1130166
| Field | Detail |
|---|---|
| Company | Cyclacel Pharmaceuticals, INC. (BGMSP) |
| Form Type | 8-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, sec-filing
Related Tickers: CYCC
TL;DR
Cyclacel dropped an 8-K detailing its financial condition as of May 14, 2025.
AI Summary
Cyclacel Pharmaceuticals, Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition as of May 14, 2025. The filing details financial statements and exhibits related to the company's performance.
Why It Matters
This 8-K filing provides investors with crucial updates on Cyclacel Pharmaceuticals' financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Numbers
- 20250514 — Report Date (Date of earliest event reported)
- 20250515 — Filing Date (Date the report was filed with the SEC)
Key Players & Entities
- Cyclacel Pharmaceuticals, Inc. (company) — Registrant
- 0001130166 (company) — Central Index Key
- 911766850 (company) — EIN
- 200 CONNELL DRIVE (company) — Business Address Street 1
- BERKELEY HEIGHTS (company) — Business Address City
- NJ (company) — Business Address State
- 07922 (company) — Business Address Zip
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
What is the exact name of the company filing this report?
The exact name of the registrant is Cyclacel Pharmaceuticals, Inc.
On what date is the financial information reported?
The financial information is reported as of May 14, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on May 15, 2025.
What is the company's state of incorporation?
The company is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding Cyclacel Pharmaceuticals, Inc. (BGMSP).